The rapid advances in cell therapy are among the most exciting avenues for the future of biotech. As I have written before, an emerging field of cell therapies harnesses the incredible powers of induced pluripotent stem cells (iPSCs) to regenerate tissues lost and damaged in conditions like Parkinson’s disease, heart…

Written by Jürgen Eckhardt, Head of Leaps by Bayer The human immune system is one of the greatest marvels of the biological world. An army of specialized cells works together to patrol our bodies in search of viruses, bacteria, and other invaders. Our immune systems can protect us against previously…

Written by Jürgen Eckhardt, Head of Leaps by Bayer As 2021 draws to a close, I want to reflect on a year filled with challenges, inspiration — and ultimately, hope. …

Written by Jürgen Eckhardt, Head of Leaps by Bayer Nature is the source of many of our greatest inspirations and innovations. …

Written by Jürgen Eckhardt, Head of Leaps by Bayer We regularly explore how our investment approach can drive greater impact. Updating our 10 leaps is part of this evolution. Our leaps are the core of our investment approach at Leaps by Bayer. They reflect huge challenges we see in the…

Written by Jürgen Eckhardt, Head of Leaps by Bayer What do you consider the most promising medical technology of the 21st century? Breakthroughs like CRISPR and related advances in synthetic biology are creating new possibilities to shift key paradigms in health. …

Written by Jürgen Eckhardt, Head of Leaps by Bayer What do you think of when I say the word “drug”? Chances are that you think of pills, chemical formulations that we take to treat everything from common, everyday pains to chronic diseases. Drug molecules from aspirin to statins to antibiotics…

Written by Jürgen Eckhardt, Head of Leaps by Bayer Proteins are the building blocks of the living world. These tiny, molecular machines, honed through billions of years of evolution, are the workhorses of biology that make life possible. Proteins can convert sunlight into sugar and transform toxic waste into harmless…

Written by Jürgen Eckhardt, Head of Leaps by Bayer We’re at a critical moment in human history. Never before have we had more technological know-how, innovation, and hunger for impact-driven investments that can truly make the world a better place for people and the planet. At the same time, we…